510(k) Report

510(k) · Cleared

Cleared

Modified Pva-Plus Foam Embolization Particles and Maxistat and Microstat Pva Foam Embolization Particles

K053548510(k) TraditionalCleared Jan 30, 200641-day reviewClass II21 CFR 882.5950

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Protein Polymer Technologies, Inc. · HCG Device, Neurovascular Embolization

Cleared on Jan 30, 2006 as substantially equivalent to K001678 (Surgica Corp., 2001) and 2 other predicates after a 41-day review. Its family tree reaches back 2 generations to 2001. 3 later devices descend from it.

Decided
Jan 30, 2006
Review
41 days
Class
Class II
Product code
HCG
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K001678 (2001). 3 ancestors in all. 3 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2006: 1 descendant cleared2008: 2 descendants clearedK001678 · Pva Foam Embolization Particles · Surgica Corp. · 2001K020033 · Maxistat Pva Foam Embolization Particles · Surgica Corp. · 2002200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 3 descendants K020033 · Maxistat Pva Foam Embolization Particles · Surgica Corp. · 2002K001678 · Pva Foam Embolization Particles · Surgica Corp. · 20010
  1. Root · 2 generations backK001678 Pva Foam Embolization ParticlesSurgica Corp. · 2001
  2. 1 generation backK020033 Maxistat Pva Foam Embolization ParticlesSurgica Corp. · 2002
  3. This deviceK053548 Modified Pva-Plus Foam Embolization Particles and Maxistat and…Protein Polymer Technologies, Inc. · 2006
  4. Descendant · cites it directly · 1 of its ownK061790 Pva Plus, Maxistat Pva, Microstat Pva Foam Embolization ParticlesProtein Polymer Technologies, Inc. · 2006
  5. Descendant · cites it directly · 0 of its ownK073544 Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience…Rj Medical, Inc. · 2008
  6. Descendant · cites it directly · 0 of its ownK073419 Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience…Rj Medical, Inc. · 2008

Most influential descendants

Showing 3 of 3 · See all
  • K061790Pva Plus, Maxistat Pva, Microstat Pva Foam Embolization ParticlesProtein Polymer Technologies, Inc. · 2006 · cites it directly1descendant
  • K073544Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva Foam…Rj Medical, Inc. · 2008 · cites it directly0descendants
  • K073419Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva Embolization…Rj Medical, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K001678Pva Foam Embolization ParticlesSurgica Corp.2001—
−1K020033Maxistat Pva Foam Embolization ParticlesSurgica Corp.2002—
0 (this device)K053548Modified Pva-Plus Foam Embolization Particles and Maxistat and Microstat Pva…Protein Polymer Technologies, Inc.2006—
+1K061790Pva Plus, Maxistat Pva, Microstat Pva Foam Embolization ParticlesProtein Polymer Technologies, Inc.2006—
+1K073544Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva…Rj Medical, Inc.2008—
+1K073419Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva…Rj Medical, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200820
FIG. 1 — Lineage of K053548, 2001–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HCG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HCG device

  1. #1 K252700 Optima Coil System (Optima Packing Coil System)score 20.6 · 26 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K001678Pva Foam Embolization Particles
Summary page 1
…The subject devices are su~bstantially equnival ent to the following2 pied icate devices: *Pva-Pli/A "I FoamiFinbolization Particles (Stirgica Corp).: K00 1678) * MutiSiat "I Pva Foam Em bol ization Particles (Surgi ca Corp.: K02003 3) *Miu roStat "' Pva Foam Em bol iz…
Surgica Corp.2001—
*K020033Maxistat Pva Foam Embolization Particles
Summary page 1
…cate devices: *Pva-Pli/A "I FoamiFinbolization Particles (Stirgica Corp).: K00 1678) * MutiSiat "I Pva Foam Em bol ization Particles (Surgi ca Corp.: K02003 3) *Miu roStat "' Pva Foam Em bol izati on Particles (Surgioca Corp.; K0326 19) 5.4 Device Description The s…
Surgica Corp.2002—
*K032619Microstat Pva Foam Embolization Particles
Summary page 1
…0 1678) * MutiSiat "I Pva Foam Em bol ization Particles (Surgi ca Corp.: K02003 3) *Miu roStat "' Pva Foam Em bol izati on Particles (Surgioca Corp.; K0326 19) 5.4 Device Description The subject devices are particles of nonabsorbable synthetic polyvinyl alcohlol (Pva)…
Surgica Corp.2004—

Also cleared against K001678: 4 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K061790Pva Plus, Maxistat Pva, Microstat Pva Foam Embolization ParticlesProtein Polymer Technologies, Inc.20061
K073544Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva Foam…Rj Medical, Inc.20080
K073419Pva Plus Vial Pva Foam Embolization Particles, Pva Plus Convenience Kit Pva Embolization…Rj Medical, Inc.20080

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 2 companies; a new generation was cleared every 3.7 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K061790 (Protein Polymer Technologies, Inc., 2006) has gone furthest, with 1 descendant of its own.
  • 4 other devices also cite its predicate K001678.

How does its category compare?

All HCG devices

HCG Device, Neurovascular Embolization: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HCG

3in 2025

2007: 82008: 92009: 72010: 82011: 92012: 72013: 72014: 52015: 52016: 72017: 52018: 42019: 12020: 22021: 52022: 32023: 22024: 42025: 32026 (partial year): 4
2007high 9 (2008) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HCG

107in 2025

2007: 50 days median2008: 71 days median2009: 48 days median2010: 72 days median2011: 78 days median2012: 30 days median2013: 67 days median2014: 66 days median2015: 60 days median2016: 37 days median2017: 97 days median2018: 173 days median2021: 103 days median2022: 114 days median2024: 49 days median2025: 107 days median2026 (partial year): 30 days median
2007high 173 (2018) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HCG

1in 2025

2007: 12008: 32010: 22011: 12013: 22014: 42022: 22024: 12025: 1, 1 Class I2026 (partial year): 1
2007high 4 (2014) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · HCG

537in 2025

2007: 3262008: 7302009: 8212010: 8512011: 8942012: 1,1462013: 1,1032014: 1,7292015: 1,5982016: 1,9912017: 2,4942018: 2,0582019: 1,7632020: 1,7542021: 2,2682022: 6632023: 5682024: 5522025: 537
2007high 2,494 (2017) · low 326 (2007)2025

MAUDE reports naming product code HCG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078501326
20089713730
20097480821
20108722851
20119781894
201273001,146
201376721,103
201456641,729
201556001,598
201673701,991
201759702,494
2018417302,058
20191—01,763
20202—01,754
2021510302,268
202231142663
20232—0568
20244491552
202531071 (1)537
20264301—

What is it indicated for?

PVA particles may be used for vascular occlusion of blood vessels within the neurovascular systems. They are intended for use in the endovascular management of arteriovenous malformations (AVMs) and neoplastic lesions when presurgical devascularization is desirable.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K053548: Modified Pva-Plus Foam Embolization Particles and Maxistat and Microstat Pva Foam Embolization Particles.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K053548

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026